miRNA |
Drug Name |
CID |
NSC |
FDA |
Effect/Pattern |
Detection Method |
Level |
Phenotype |
Condition |
hsa-mir-629 |
Paroxetine |
43815 |
|
approved |
sensitive |
|
High |
Normal |
lymphoblastoid cell line |
hsa-mir-629 |
Ceritinib |
57379345 |
NSC776422 |
approved |
sensitive |
|
High |
Non-Small Cell Lung Cancer |
cell line (H3122, H2228) |
hsa-miR-629 |
Doxorubicin |
31703 |
NSC123127 |
approved |
resistant |
|
High |
Breast Cancer |
cell line (MCF-7) |
hsa-miR-629 |
Verapamil |
2520 |
NSC272366 |
approved |
resistant |
|
High |
Breast Cancer |
cell line (MCF-7) |
hsa-miR-629 |
Daunorubicin |
30323 |
NSC82151 |
approved |
resistant |
|
High |
Lymphoblastic Leukemia |
tissue |
hsa-miR-629 |
Vincristine |
5978 |
|
approved |
resistant |
|
High |
Lymphoblastic Leukemia |
tissue |
hsa-miR-629 |
L-Asparaginase |
|
|
|
resistant |
|
High |
Lymphoblastic Leukemia |
tissue |
hsa-miR-629 |
Prednisolone |
5755 |
NSC9120 |
approved |
resistant |
|
High |
Lymphoblastic Leukemia |
tissue |
hsa-miR-629 |
Paroxetine |
43815 |
|
approved |
resistant |
|
High |
Normal |
lymphoblastoid cell line |
hsa-miR-629 |
Sunitinib |
5329102 |
NSC750690 |
approved |
sensitive |
|
High |
Renal Cell Cancer |
tissue |
hsa-miR-629 |
Gemcitabine |
60750 |
NSC613327 |
approved |
resistant |
|
High |
Pancreatic Cancer |
cell line (PANC-1) |
hsa-miR-629 |
Fluorouracil |
3385 |
NSC19893 |
approved |
resistant |
|
High |
Pancreatic Cancer |
cell line (PANC-1) |
hsa-miR-629 |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
High |
Non-Small Cell Lung Cancer |
cell line (A549) |
hsa-miR-629 |
1'-Acetoxychavicol acetate |
119104 |
NSC711510 |
|
resistant |
|
Low |
Cervical Cancer |
cell line (Ca Ski, SiHa) |
hsa-miR-629 |
Fulvestrant |
17756771 |
NSC719276 |
approved |
sensitive |
|
High |
Breast Cancer |
cell line (MCF-7) |
hsa-miR-629 |
Sunitinib |
5329102 |
NSC750690 |
approved |
sensitive |
|
High |
Renal Cell Cancer |
tissue |
hsa-mir-629 |
Dabrafenib |
44462760 |
NSC764134 |
approved |
sensitive |
|
|
|
cell line (A375) |
hsa-mir-629 |
Androstenedione |
6128 |
NSC9563 |
|
sensitive |
|
|
|
cell line (MCF-7) |
hsa-mir-629 |
Androstenedione+Anastrozole |
|
|
|
sensitive |
|
|
|
cell line (MCF-7) |
hsa-mir-629 |
Androstenedione+Letrozole |
|
|
|
sensitive |
|
|
|
cell line (MCF-7) |
hsa-mir-629 |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (KYSE) |
hsa-mir-629 |
Ceritinib |
57379345 |
NSC776422 |
approved |
sensitive |
|
|
|
cell line (H3122) |
hsa-miR-629 |
Paclitaxel |
36314 |
NSC125973 |
approved |
resistant |
|
|
|
cell line (HeyA8) |
hsa-miR-629 |
Testosterone+Exemestane |
|
|
|
sensitive |
|
|
|
cell line (MCF-7) |
hsa-miR-629 |
Testosterone+Tamoxifen |
|
|
|
sensitive |
|
|
|
cell line (MCF-7) |
hsa-miR-629 |
Fluorouracil |
3385 |
NSC19893 |
approved |
resistant |
|
|
|
cell line (KM12C) (72 h) |
hsa-miR-629 |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (RPMI2650) |
hsa-miR-629 |
Sunitinib |
5329102 |
NSC750690 |
approved |
resistant |
|
|
|
tissue (CardA) |
hsa-miR-629 |
Paclitaxel |
36314 |
NSC125973 |
approved |
resistant |
|
|
|
cell line (SKOV3) |
hsa-miR-629 |
Pegylated interferon alpha+Ribavirin |
|
|
|
sensitive |
|
|
|
tissue (chronic hepatitis C) |
hsa-miR-629 |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
|
|
cell line (IGROV-1) |
hsa-miR-629 |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
|
|
cell line (A549) |
hsa-miR-629 |
Gemcitabine |
60750 |
NSC613327 |
approved |
resistant |
|
|
|
cell line (Panc1-GR3) |
hsa-miR-629 |
Gemcitabine |
60750 |
NSC613327 |
approved |
resistant |
|
|
|
cell line (Panc1-GR4) |
hsa-miR-629 |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
|
|
cell line (H23) |
hsa-miR-629 |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (OVCAR3) |
hsa-miR-629 |
Paclitaxel/Docetaxel/Vinorelbine/Doxorubicin/Etoposide/Methotrexate/Gemcitabine |
|
|
|
resistant |
|
|
|
cell line (Bats-72) |
hsa-miR-629-5p |
(1'S,8'R)-9',10'-dibromospiro[1,3-dithiolane-2,11'-tricyclo[6.3.1.02,7]dodeca-2,4,6,9-tetraene] |
389921 |
NSC686573 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(1-(((2-amino-5-cyano-4-pyrimidinyl)amino)methyl)-3-(2-phenylethyl)cyclobutyl)methyl acetate |
385201 |
NSC676315 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(1-(((2-amino-6-chloro-4-pyrimidinyl)amino)methyl)-3-isopropylcyclobutyl)methanol |
385230 |
NSC676343 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(11E)-11-(3-aminopropylidene)-15,16-dimethoxy-20-methyl-5,7-dioxa-20-azapentacyclo[10.8.0.02,10.04,8.013,18]icosa-1(12),2,4(8),9,13,15,17-heptaen-19-one |
9978660 |
NSC724562 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(11E)-11-(6-aminohexylidene)-15,16-dimethoxy-20-methyl-5,7-dioxa-20-azapentacyclo[10.8.0.02,10.04,8.013,18]icosa-1(12),2,4(8),9,13,15,17-heptaen-19-one |
45027835 |
NSC727049 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(13r,17r)-13-methyl-17-[(2r)-6-methylheptan-2-yl]-5,6,9,10,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-1,4-dione |
54613423 |
NSC750440 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(1r)-3,3-dibromocamphor |
376765 |
NSC657822 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(2,3-dihydroxyphenyl)-[1-[(4-fluorophenyl)methyl]-4-hydroxyindol-3-yl]methanone |
42624812 |
NSC746053 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(2E)-2-[(4-chlorophenyl)methylidene]-5-(morpholin-4-ylmethyl)cyclopentan-1-one;hydrochloride |
50988453 |
NSC639517 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(2E)-2-hexylidene-5-(morpholin-4-ylmethyl)cyclopentan-1-one;hydrochloride |
21141930 |
NSC639503 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(2e,4e,6z,8e)-n-(1,3-benzodioxol-5-yl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenamide |
24202490 |
NSC672131 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(2E,6E)-2,6-bis[(4-bromophenyl)methylidene]cyclohexan-1-one |
5716584 |
NSC632831 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(2R,6R)-9,11-dibromo-5-oxa-10-thia-3-azatricyclo[6.3.0.02,6]undeca-1(11),8-diene-4,7-dione |
383027 |
NSC671009 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(2z)-2-[(4-hydroxyphenyl)methylidene]-5-methoxy-1-benzofuran-3-one |
54613041 |
NSC747169 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(3-methoxyphenyl) 2-(5-chloro-2-methylanilino)-6-(trifluoromethyl)pyridine-3-carboxylate |
24204985 |
NSC733901 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(3E)-3-[[3-[1-(4-fluorophenyl)sulfonylpiperidin-4-yl]imidazo[1,5-a]pyridin-1-yl]methylidene]-1H-indol-2-one |
54613720 |
NSC750970 |
|
resistant |
|
|
|
|
hsa-miR-629-5p |
(3e)-3-[[6-[(e)-(2-oxo-1h-indol-3-ylidene)methyl]pyridin-2-yl]methylidene]-1h-indol-2-one |
5473214 |
NSC724448 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(3E)-3-[1-(4-chloroanilino)ethylidene]oxolan-2-one |
820318 |
NSC680781 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(3E,5E)-1-acetyl-3,5-dibenzylidenepiperidin-4-one |
5387998 |
NSC630599 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(3E,5E)-3,5-bis[(3,4-dichlorophenyl)methylidene]-1-[3-(dimethylamino)propanoyl]piperidin-4-one;hydrochloride |
5388808 |
NSC638645 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(3R,5R,8R,9S,10S,13R,14S,17R)-17-[(2R)-4-(4,5-dihydro-1H-imidazol-2-yl)butan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol |
391085 |
NSC689620 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(3S)-3-[(5R)-9-bromo-4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-6,7-dimethoxy-3H-2-benzofuran-1-one |
10255081 |
NSC733397 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(3s,6s)-3,6-bis(5-bromo-1h-indol-3-yl)piperazine-2,5-dione |
6712394 |
NSC679833 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(3s,8r,9s,10r,13s,14s,16e)-3-hydroxy-10,13-dimethyl-16-[(4-nitrophenyl)methylidene]-2,3,4,7,8,9,11,12,14,15-decahydro-1h-cyclopenta[a]phenanthren-17-one |
5472098 |
NSC716261 |
|
resistant |
|
|
|
|
hsa-miR-629-5p |
(3z)-1-(2,6-dichlorophenyl)-3-[(4-hydroxy-3,5-dimethoxyphenyl)methylidene]indol-2-one |
60147866 |
NSC752703 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(3z)-3-[[3-[2-(4-methoxyphenyl)-2-oxoethoxy]phenyl]methylidene]-6-methylthiochromen-4-one |
45028770 |
NSC744075 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(3z)-5-hydroxy-3-[(3,4,5-trimethoxyphenyl)methylidene]-1h-indol-2-one |
24205822 |
NSC736802 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(3Z,5E)-3,5-dibenzylidene-1-[(E)-3-phenylprop-2-enoyl]piperidin-4-one |
5351375 |
NSC638634 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(4-methylphenyl) (3E,5E)-3,5-dibenzylidene-4-oxopiperidine-1-carboxylate |
5388005 |
NSC630606 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(4-nitrophenyl) (3E,5E)-3,5-dibenzylidene-4-oxopiperidine-1-carboxylate |
5388007 |
NSC630608 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(4-oxo-2-phenylchromen-8-yl)methyl carbamimidothioate |
431425 |
NSC293046 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(4aR,9aR)-9-(4-methylphenyl)sulfonyl-3,4,4a,9a-tetrahydrocarbazole |
372866 |
NSC648556 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(4e)-4-(3h-1,3-benzothiazol-2-ylidene)-1-[4-(difluoromethylsulfanyl)phenyl]-5-iminopyrrolidin-2-one |
135543874 |
NSC744116 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(4Z,9Z,14Z)-2,2,7,7,12,12,17,17-octamethyl-21-oxabicyclo[16.2.1]henicosa-1(20),4,9,14,18-pentaene-3,6,8,11,13,16-hexone |
5387611 |
NSC625154 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(5ar,6r,8ar)-6-(1,5-dimethylhexyl)-5a-methyl-2,3,4,5,6,7,8,8a-octahydro-1h-cyclopenta[b]azepine |
403828 |
NSC719362 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(5E)-2-(morpholin-4-ylmethyl)-5-nonylidenecyclopentan-1-one;hydrochloride |
54612513 |
NSC639505 |
|
sensitive |
|
|
|
|
hsa-miR-629-5p |
(5E)-3-(4-chlorophenyl)-1,1-dioxo-2-phenyl-5-[(3,4,5-trimethoxyphenyl)methylidene]-1,3-thiazolidin-4-one |
5470264 |
|